From the Leader's Desk
I am delighted to share that Syngene sustained positive performance in the fourth quarter of the prior fiscal year, delivering strong full-year results. Our full-year revenue from operations was up 23%, exceeding the upgraded
guidance provided earlier in the year (read press release).
We look forward to continued growth in the coming year across our business divisions of Discovery, Development, and Manufacturing.
In other news, as part of our reach out to the scientific community, we recently conducted a scientific symposium at MassBio, Cambridge, titled "Proximity Matters" on targeted protein degradation and stabilization. The
symposium received an overwhelming favorable response.
As before, this newsletter edition has an interesting line-up of articles for you.
Happy reading!